• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可降解葡聚糖水凝胶:模型蛋白从圆柱体和微球中的控释

Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres.

作者信息

Franssen O, Vandervennet L, Roders P, Hennink W E

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Universiteit Utrecht, P.O. Box 80.082 3508 TB, Utrecht, The Netherlands.

出版信息

J Control Release. 1999 Aug 5;60(2-3):211-21. doi: 10.1016/s0168-3659(99)00074-7.

DOI:10.1016/s0168-3659(99)00074-7
PMID:10425327
Abstract

The preparation of protein-loaded degradable hydroxyethyl methacrylated dextran (dex-HEMA) hydrogels, cylindrical macroscopic gels as well as microspheres, is described. The hydrogels were degradable under physiological conditions (pH 7.0 and 37 degrees C), due to the presence of hydrolytically sensitive carbonate esters in the crosslinks of the gels. The degradation of dex-HEMA hydrogels was studied by swelling measurements and the release of dextran from the matrices. The hydrogels showed a progressive swelling in time, followed by a dissolution phase. The total degradation time ranged from 25 to more than 80 days and depended on the initial water content of the gels and the degree of substitution (DS) of dex-HEMA. IgG-loaded dex-HEMA microspheres (volume mean diameter of about 10 microm) were prepared with a high encapsulation efficiency (83-100%). Furthermore, it was possible to entrap more than 90% of the protein in both dex-HEMA microspheres and macroscopic hydrogels. Therefore, it was possible to obtain a completely degradation-controlled protein release. For degrading macroscopic dex-HEMA hydrogels as well as microspheres, a biphasic release of IgG was observed. The release was always faster during the second phase than during the first phase. Microspheres with an initial water content of 60% (w/w) had a significant release of 25-40% of the encapsulated IgG during the first phase. For microspheres with a water content of 50% (w/w), the released amount of protein during the first phase was marginal (less than 15%), resulting in delayed release profiles. The delay time increased with increasing crosslink density (determined by the DS and the water content) of the gels (longer degradation time) and decreasing pH of the incubation buffer (decreasing degradation rate). In addition, the delay time was considerably shorter (5-15 days) for dex-HEMA microspheres than for macroscopic hydrogels (10-37 days), due to a higher surface-to-volume ratio for the microspheres. This paper shows that the release of IgG from dex-HEMA hydrogels can be modulated by the composition (water content and DS) and the geometry of the gel (microspheres versus macroscopic gels).

摘要

本文描述了载有蛋白质的可降解甲基丙烯酸羟乙酯葡聚糖(dex-HEMA)水凝胶、圆柱形宏观凝胶以及微球的制备方法。由于凝胶交联中存在对水解敏感的碳酸酯,这些水凝胶在生理条件(pH 7.0和37℃)下可降解。通过溶胀测量以及葡聚糖从基质中的释放来研究dex-HEMA水凝胶的降解。水凝胶随时间逐渐溶胀,随后进入溶解阶段。总降解时间为25至80多天,这取决于凝胶的初始含水量以及dex-HEMA的取代度(DS)。制备了载有IgG的dex-HEMA微球(体积平均直径约为10微米),其包封效率较高(83 - 100%)。此外,在dex-HEMA微球和宏观水凝胶中均能包封超过90%的蛋白质。因此,有可能实现完全受降解控制的蛋白质释放。对于降解的宏观dex-HEMA水凝胶以及微球,观察到IgG呈现双相释放。第二阶段的释放总是比第一阶段更快。初始含水量为60%(w/w)的微球在第一阶段有25 - 40%的包封IgG显著释放。对于含水量为50%(w/w)的微球,第一阶段蛋白质的释放量很少(小于15%),导致释放曲线延迟。延迟时间随着凝胶的交联密度(由DS和含水量决定,降解时间更长)增加以及孵育缓冲液pH值降低(降解速率降低)而增加。此外,由于微球的表面积与体积比更高,dex-HEMA微球的延迟时间(5 - 15天)比宏观水凝胶(10 - 37天)短得多。本文表明,IgG从dex-HEMA水凝胶中的释放可通过凝胶的组成(含水量和DS)以及几何形状(微球与宏观凝胶)进行调节。

相似文献

1
Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres.可降解葡聚糖水凝胶:模型蛋白从圆柱体和微球中的控释
J Control Release. 1999 Aug 5;60(2-3):211-21. doi: 10.1016/s0168-3659(99)00074-7.
2
Controlled release of a model protein from enzymatically degrading dextran microspheres.模型蛋白从酶解葡聚糖微球中的控释。
J Control Release. 1999 May 20;59(2):219-28. doi: 10.1016/s0168-3659(98)00193-x.
3
Release of recombinant human interleukin-2 from dextran-based hydrogels.从基于葡聚糖的水凝胶中释放重组人白细胞介素-2。
J Control Release. 2002 Jan 17;78(1-3):1-13. doi: 10.1016/s0168-3659(01)00483-7.
4
Tailoring the swelling pressure of degrading dextran hydroxyethyl methacrylate hydrogels.定制可降解甲基丙烯酸羟乙酯葡聚糖水凝胶的溶胀压力
Biomacromolecules. 2003 May-Jun;4(3):691-5. doi: 10.1021/bm020129w.
5
Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics.新型甲基丙烯酸缩水甘油酯修饰葡聚糖(Dex-GMA)/明胶水凝胶支架,含负载骨形态发生蛋白的微球:配方与特性
J Control Release. 2007 Mar 12;118(1):65-77. doi: 10.1016/j.jconrel.2006.11.016. Epub 2006 Nov 24.
6
In vivo biocompatibility of dextran-based hydrogels.基于葡聚糖的水凝胶的体内生物相容性。
J Biomed Mater Res. 2000 Jun 5;50(3):397-404. doi: 10.1002/(sici)1097-4636(20000605)50:3<397::aid-jbm14>3.0.co;2-a.
7
Physically crosslinked dextran hydrogels by stereocomplex formation of lactic acid oligomers: degradation and protein release behavior.通过乳酸低聚物的立体络合形成的物理交联葡聚糖水凝胶:降解和蛋白质释放行为
J Control Release. 2001 Apr 28;71(3):261-75. doi: 10.1016/s0168-3659(01)00228-0.
8
A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats.大鼠皮下注射交联葡聚糖或聚乳酸-乙醇酸微球后的生物相容性比较研究
J Biomed Mater Res. 2001 Sep 15;56(4):600-9. doi: 10.1002/1097-4636(20010915)56:4<600::aid-jbm1133>3.0.co;2-i.
9
In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts.用人成纤维细胞测试的可生物降解葡聚糖基水凝胶的体外生物相容性。
Biomaterials. 2001 Jun;22(11):1197-203. doi: 10.1016/s0142-9612(00)00266-0.
10
Effect of excipients on the encapsulation efficiency and release of human growth hormone from dextran microspheres.辅料对人生长激素从右旋糖酐微球中的包封率及释放的影响。
Eur J Pharm Biopharm. 2007 Nov;67(3):589-96. doi: 10.1016/j.ejpb.2007.04.011. Epub 2007 May 4.

引用本文的文献

1
Nanoparticle-in-Hydrogel Delivery System for the Sequential Release of Two Drugs.用于两种药物顺序释放的水凝胶纳米颗粒递送系统
Pharmaceutics. 2025 Jan 17;17(1):127. doi: 10.3390/pharmaceutics17010127.
2
Innovative Strategies for Drug Delivery to the Ocular Posterior Segment.药物递送至眼后段的创新策略。
Pharmaceutics. 2023 Jul 1;15(7):1862. doi: 10.3390/pharmaceutics15071862.
3
Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds.眼部视网膜病变的给药系统:玻璃体内水凝胶作为缓释支架的光明未来。
Pharmaceutics. 2023 May 12;15(5):1484. doi: 10.3390/pharmaceutics15051484.
4
Ocular Delivery of Therapeutic Proteins: A Review.治疗性蛋白质的眼部给药:综述
Pharmaceutics. 2023 Jan 6;15(1):205. doi: 10.3390/pharmaceutics15010205.
5
Recent Strategies for the Immobilization of Therapeutic Enzymes.治疗性酶固定化的最新策略。
Polymers (Basel). 2022 Mar 30;14(7):1409. doi: 10.3390/polym14071409.
6
Cell-Inspired All-Aqueous Microfluidics: From Intracellular Liquid-Liquid Phase Separation toward Advanced Biomaterials.受细胞启发的全水性微流体:从细胞内液-液相分离到先进生物材料
Adv Sci (Weinh). 2020 Feb 11;7(7):1903359. doi: 10.1002/advs.201903359. eCollection 2020 Apr.
7
Controlled Angiogenesis in Peptide Nanofiber Composite Hydrogels.肽纳米纤维复合水凝胶中的可控血管生成
ACS Biomater Sci Eng. 2015 Sep 14;1(9):845-854. doi: 10.1021/acsbiomaterials.5b00210. Epub 2015 Aug 20.
8
Two-step self-assembly of liposome-multidomain peptide nanofiber hydrogel for time-controlled release.用于定时释放的脂质体-多结构域肽纳米纤维水凝胶的两步自组装
Biomacromolecules. 2014 Oct 13;15(10):3587-95. doi: 10.1021/bm500856c. Epub 2014 Sep 9.
9
Hydrogels and scaffolds for immunomodulation.用于免疫调节的水凝胶和支架
Adv Mater. 2014 Oct;26(38):6530-41. doi: 10.1002/adma.201402105. Epub 2014 Aug 25.
10
Engineering dextran-based scaffolds for drug delivery and tissue repair.基于葡聚糖的支架工程用于药物输送和组织修复。
Nanomedicine (Lond). 2012 Nov;7(11):1771-84. doi: 10.2217/nnm.12.149.